Labcorp Holdings (LTS:0JSY) Cyclically Adjusted Revenue per Share: $153.54 (As of Mar. 2026)


LTS:0JSY Labcorp Holdings Inc LTS:0JSY
81 GF Score
Price $285.29
GF Value $269.55
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Labcorp Holdings Cyclically Adjusted Revenue per Share?

Labcorp Holdings LTS:0JSY 81 Cyclically Adjusted Revenue per Share is $153.54 as of Mar. 2026. GuruFocus rates LTS:0JSY with a GF Score™ of 81/100 and a GF Value™ of $269.55 (Fairly Valued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Labcorp Holdings's adjusted revenue per share for the three months ended in Mar. 2026 was $42.673. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $153.54 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Labcorp Holdings's average Cyclically Adjusted Revenue Growth Rate was 6.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 9.50% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 11.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Labcorp Holdings was 12.80% per year. The lowest was -2.30% per year. And the median was 9.25% per year.

As of today (2026-07-06), Labcorp Holdings's current stock price is $285.29. Labcorp Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $153.54. Labcorp Holdings's Cyclically Adjusted PS Ratio of today is 1.86.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Labcorp Holdings was 2.52. The lowest was 1.08. And the median was 1.78.


Labcorp Holdings  (LTS:0JSY) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Labcorp Holdings's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=285.29/153.54
=1.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Labcorp Holdings was 2.52. The lowest was 1.08. And the median was 1.78.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Labcorp Holdings Cyclically Adjusted Revenue per Share Related Terms


Labcorp Holdings Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Labcorp Holdings's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labcorp Holdings Cyclically Adjusted Revenue per Share Chart

Labcorp Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 112.36 126.22 132.10 142.72 151.58

Labcorp Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 143.29 147.16 148.93 151.58 153.54

LTS:0JSY vs DGX, GH, MTD: Cyclically Adjusted Revenue per Share Comparison

For the Diagnostics & Research subindustry, Labcorp Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Labcorp Holdings Cyclically Adjusted PS Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Labcorp Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Labcorp Holdings's Cyclically Adjusted PS Ratio falls into.


LTS:0JSY
81GF Score
Labcorp Holdings Inc LTS:0JSY
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Labcorp Holdings Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Labcorp Holdings's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=42.673/330.2130*330.2130
=42.673

Current CPI (Mar. 2026) = 330.2130.

Labcorp Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 23.350 241.018 31.991
201609 23.019 241.428 31.484
201612 22.366 241.432 30.591
201703 23.142 243.801 31.344
201706 24.380 244.955 32.866
201709 25.279 246.819 33.820
201712 26.417 246.524 35.385
201803 27.546 249.554 36.449
201806 27.828 251.989 36.467
201809 27.569 252.439 36.063
201812 27.572 251.233 36.240
201903 28.052 254.202 36.440
201906 29.167 256.143 37.601
201909 29.791 256.759 38.314
201912 30.137 256.974 38.726
202003 29.051 258.115 37.166
202006 28.340 257.797 36.301
202009 39.716 260.280 50.387
202012 45.674 260.474 57.903
202103 42.249 264.877 52.670
202106 39.111 271.696 47.535
202109 41.839 274.310 50.366
202112 11.125 278.802 13.176
202203 41.485 287.504 47.648
202206 31.545 296.311 35.154
202209 31.607 296.808 35.164
202212 32.844 296.797 36.542
202303 34.133 301.836 37.342
202306 34.087 305.109 36.892
202309 35.136 307.789 37.696
202312 35.477 306.746 38.191
202403 37.504 312.332 39.651
202406 38.208 314.175 40.158
202409 38.886 315.301 40.725
202412 39.589 315.605 41.421
202503 39.681 319.799 40.973
202506 42.042 322.561 43.039
202509 42.575 324.800 43.285
202512 42.257 324.054 43.060
202603 42.673 330.213 42.673

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $153.54 mean?
Labcorp Holdings (LTS:0JSY) has a Cyclically Adjusted Revenue per Share of $153.54 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Labcorp Holdings and its competitors.
Is Labcorp Holdings' Cyclically Adjusted Revenue per Share too high?
Labcorp Holdings' current Cyclically Adjusted Revenue per Share is $153.54. Overall, Labcorp Holdings has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Labcorp Holdings' Cyclically Adjusted Revenue per Share compare to DGX and GH?
Labcorp Holdings' Cyclically Adjusted Revenue per Share of $153.54 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Labcorp Holdings and its competitors. Labcorp Holdings's current Cyclically Adjusted Revenue per Share is $153.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labcorp Holdings stock overvalued right now?
Based on GuruFocus' analysis, Labcorp Holdings (LTS:0JSY) is currently considered Fairly Valued. The stock's GF Value™ is $269.55, compared to a current price of $285.29 — trading 5.8% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is $153.54. Labcorp Holdings' overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Labcorp Holdings (LTS:0JSY), the current Cyclically Adjusted Revenue per Share is $153.54 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Labcorp Holdings (LTS:0JSY) Overvalued in 2026?

Based on GuruFocus' analysis, Labcorp Holdings stock appears to be overvalued. The current stock price of $285.29 is trading 5.8% above its estimated GF Value™ of $269.55. GuruFocus considers Labcorp Holdings to be Fairly Valued.

Key valuation signals for LTS:0JSY:

  • Cyclically Adjusted Revenue per Share: $153.54
  • GF Value™: $269.55 vs. price of $285.29 (5.8% above fair value)
  • GF Score™: 81/100 with 6 warning signs

No single metric tells the full story. See the LTS:0JSY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Labcorp Holdings Business Description

Other Exchanges LH:USAN6B:Germany
Address 358 South Main Street, Burlington, NC, USA, 27215
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
81GF Score

Get the complete analysis for LTS:0JSY

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$285.29
Price
$269.55
GF Value